Invaryant and CardieX partner to expand RPM during clinical trials

The AI-enabled data company will integrate ATCOR and CONNEQT's technology into its platform in early 2023 to monitor maternal health and cardiovascular diseases.

from MobiHealthNews https://ift.tt/JmT5usd
https://ift.tt/27bclXT